This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

C. W. WEISSER, M.D.

AMA Arch Ophthalmol. 1954;51(5):681-686.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

WE CONSTANTLY search for new or improved medication which will relieve pain and speed healing. In treating corneal diseases we often partially defeat one purpose to accomplish another. Some of our commonly used agents, for example, tetracaine and hydrous wool fat U. S. P. (lanolin), while relieving pain or serving as a vehicle, may delay corneal healing. If we can find an agent which both relieves pain and stimulates or supports healing, we shall come close to an ideal medicine for treating corneal disease. In thromboplastin we have such an agent. When properly used, it relieves pain quickly and permits rapid replacement of corneal epithelium. My colleagues and I have used it in the treatment of about 100 corneal lesions of various types, with very satisfying clinical results. We have also attempted to verify the work in laboratory animals, with some encouraging and stimulating experiments.

The material we used in . . . [Full Text PDF of this Article]

Author Affiliations
PITTSBURGH

Footnotes
Read before the Section on Ophthalmology at the 102nd Annual Meeting of the American Medical Association, New York, June 4, 1953.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?